Full Prescribing Information
Important Safety Information
Patient Site
ABOUT TED
About TEPEZZA
TEPEZZA MOA
Phase 2/3 Clinical Trial Efficacy
Phase 4 Clinical Trial Efficacy
TEPEZZA Safety
Real Patient Results
PRESCRIBING TEPEZZA
Getting Patients Started
Setting Patient Expectations
Dosing Information
Preparation and Administration
SUPPORT AND RESOURCES
Support for Your Patients
Downloads
Request a Representative
Find a TED Specialist
Sign Up for Updates
Search
TOP SEARCHES
Educational Resources
Payor Resources
Billing and Coding Resources
Patient Site
Full Prescribing Information
Important Safety Information
PAGE NOT FOUND
We were unable to find the web page you requested. The page may have been removed, deleted, or incorporated into another part of the website.
HOME
Top
You are now leaving the site
Are you sure you want to leave?
Are you sure you want to exit?
Your answers will not be saved.
Leaving Site
NEW phase 4, placebo-controlled, double-blind study confirms real-world efficacy in chronic Thyroid Eye Disease (TED).
LEARN MORE
© 2023 Horizon Therapeutics plc P-TEP-US-00948 04/23
Please ensure JavaScript is enabled for purposes of
website accessibility